Penserra Capital Management LLC Deciphera Pharmaceuticals, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$7.7 - $37.13 $10,241 - $49,382	-1,330 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $264 - $371	10 Added 0.76%	1,330 $45,000
Q2 2021 Aug 12, 2021	BUY	$32.73 - $47.95 $654 - $959	20 Added 1.54%	1,320 $48,000
Q1 2021 May 13, 2021	SELL	$40.39 - $56.73 $201 - $283	-5 Reduced 0.38%	1,300 $58,000
Q4 2020 Feb 12, 2021	BUY	$51.77 - $66.18 $42,606 - $54,466	823 Added 170.75%	1,305 $74,000
Q3 2020 Nov 13, 2020	BUY	$43.8 - $58.16 $21,111 - $28,033	482 New	482 $24,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.